New patent expiration for Sb Pharmco drug AVANDARYL

Copyright © DrugPatentWatch. Originally published at https://www.drugpatentwatch.com/blog/

Annual Drug Patent Expirations for AVANDARYL
Annual Drug Patent Expirations for AVANDARYL

Avandaryl is a drug marketed by Sb Pharmco and is included in one NDA. There is one patent protecting this drug and two Paragraph IV challenges.

The generic ingredient in AVANDARYL is glimepiride; rosiglitazone maleate. Additional details are available on the glimepiride; rosiglitazone maleate profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at
DrugPatentWatch - Make Better Decisions
Scroll to Top